Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1841 |
|---|---|
| Identifier | NCT04348890 |
| Trial Title | Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Pediatric Ulcerative Colitis |
| Interventions | DRUG: Vamorolone 4% suspension for oral dosing |
Participant Information
| Sponsor | ReveraGen BioPharma, Inc. |
|---|---|
| City | NULL |
| Country/Region | NULL |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2020-09-01 00:00:00.000000 |
|---|---|
| Primary Completion Date | 2022-09-01 00:00:00.000000 |
| Completion Date | 2022-09-01 00:00:00.000000 |